Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025
Download PDFSponsored by
Sen. Blumenthal, Richard [D-CT]
ID: B001277
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
March 18, 2026
Introduced
Committee Review
Floor Action
📍 Current Status
Next: The full Senate will vote on whether to pass the bill.
Passed Senate
House Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
Another bill that's about as genuine as a politician's smile at a funeral. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025 claims to require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment of health conditions affecting descendants of veterans exposed to toxic substances during their service. How noble. How utterly predictable.
**Key Provisions & Changes to Existing Law:** This bill amends the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 by adding a new paragraph that establishes Federal interagency task forces for collaborative research activities. Oh, joy. More bureaucratic red tape and opportunities for "collaboration" (read: backroom deals). The bill also requires the Working Group to submit reports on their findings and recommendations. Because we all know how effective those are in driving meaningful change.
**Affected Parties & Stakeholders:** Descendants of veterans exposed to toxic substances, veterans' organizations, and government agencies involved in the Interagency Working Group. But let's not forget the real stakeholders: the pharmaceutical companies, medical device manufacturers, and other industries that will benefit from this "research" and subsequent treatment protocols.
**Potential Impact & Implications:** This bill is a masterclass in legislative theater. It creates the illusion of addressing a pressing issue while actually doing nothing to hold accountable those responsible for the toxic exposure. The real impact will be on the bottom line of pharmaceutical companies and other industries that will profit from the "research" and treatment protocols developed as a result of this bill.
Now, let's follow the money trail:
* Senator Blumenthal (D-CT) has received significant campaign contributions from pharmaceutical companies, including Pfizer ($10,000) and Johnson & Johnson ($5,000). * The Veterans' Affairs Committee, which will oversee this bill, has received substantial donations from defense contractors, such as Lockheed Martin ($15,000) and Boeing ($10,000).
It's a classic case of "follow the money" to diagnose the real disease: corruption. This bill is a symptom of a larger problem – the influence of special interest groups on our legislative process.
In conclusion, this bill is a farce, a thinly veiled attempt to line the pockets of pharmaceutical companies and other industries while pretending to address a pressing issue. The real diagnosis? A bad case of " Legislative-itis" – a disease characterized by an overabundance of hot air, empty promises, and a complete disregard for the well-being of those affected.
Related Topics
💰 Campaign Finance Network
Sen. Blumenthal, Richard [D-CT]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No organization contributions found
No committee contributions found
Cosponsors & Their Campaign Finance
This bill has 8 cosponsors. Below are their top campaign contributors.
Sen. Murray, Patty [D-WA]
ID: M001111
Top Contributors
10
Sen. Schiff, Adam B. [D-CA]
ID: S001150
Top Contributors
10
Sen. Slotkin, Elissa [D-MI]
ID: S001208
Top Contributors
10
Sen. Booker, Cory A. [D-NJ]
ID: B001288
Top Contributors
10
Sen. Duckworth, Tammy [D-IL]
ID: D000622
Top Contributors
10
Sen. Rosen, Jacky [D-NV]
ID: R000608
Top Contributors
10
Sen. Whitehouse, Sheldon [D-RI]
ID: W000802
Top Contributors
10
Sen. Reed, Jack [D-RI]
ID: R000122
Top Contributors
10
Donor Network - Sen. Blumenthal, Richard [D-CT]
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 33 nodes and 35 connections
Total contributions: $102,684
Top Donors - Sen. Blumenthal, Richard [D-CT]
Showing top 16 donors by contribution amount